======= XPNPEP1 ======= == Gene Information == * **Official Symbol**: XPNPEP1 * **Official Name**: X-prolyl aminopeptidase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7511|7511]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQW7|Q9NQW7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=XPNPEP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20XPNPEP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602443|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Contributes to the degradation of bradykinin. Catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Arg-Pro-Pro. |Peptidase M24| |Creatinase N| |bradykinin catabolic process| |metalloaminopeptidase activity| |aminopeptidase activity| |peptide catabolic process| |manganese ion binding| |drug catabolic process| |drug metabolic process| |peptide metabolic process| |cellular amide metabolic process| |protein homodimerization activity| |organonitrogen compound catabolic process| |proteolysis| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.96| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.9| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.9| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.87| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.76| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.73| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-1.71| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.76| |[[:results:exp480|ETC-159 50μM R08 exp480]]|1.77| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|1.87| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|1.91| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.92| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.97| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.02| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.09| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.22| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17433 * **Expression level (log2 read counts)**: 6.34 {{:chemogenomics:nalm6 dist.png?nolink |}}